Nov 1, 2023 1:05:43 AM

Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth

Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.

Press

Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom LifeLines Magazine

With the onset of the COVID-19 pandemic, Sanguine, like many other companies, had to make many...

Related posts